Help us shape the future of the Legislature website!

We are redesigning our website and want your feedback. We are looking for volunteers to participate in research, and some opportunities may be paid.    Sign up to participate here!
Bill Information > SB 5391
Search for another bill or initiative:
SB 5391 - 2019-20
Requiring the disclosure of drug production in improved residential real property sales.
Revised for 1st Substitute: Concerning seller disclosure requirements in property sales.
Sponsors: Zeiger, Mullet, Padden, Das, Warnick, Hunt, Keiser
Bill History

2019 REGULAR SESSION

Jan 18
First reading, referred to Financial Institutions, Economic Development & Trade. (View Original Bill)
Jan 22
Public hearing in the Senate Committee on Financial Institutions, Economic Development & Trade at 8:30 AM. (Committee Materials)
Feb 14
Executive action taken in the Senate Committee on Financial Institutions, Economic Development & Trade at 8:00 AM. (Committee Materials)
FIET - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)
Minority; without recommendation. (Minority Report)
Feb 15
Passed to Rules Committee for second reading.
Mar 18
Senate Rules "X" file.

2020 REGULAR SESSION

Jan 13
By resolution, reintroduced and retained in present status.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos